Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is a common hormonal disorder in women, treated with lifestyle changes and hormonal therapy.

Chronic stress can cause hair loss by increasing oxidative stress, but antioxidants may help.

Dutasteride and finasteride affect different cell types differently.

The research found how GPCR Class A Rhodopsin receptors are related and suggested possible substances they interact with.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Potassium changes lead root hair growth, with calcium and other factors regulating the process.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

Neuropeptides affect skin inflammation, repair, and hair growth, with potential for therapy.

Blackcurrant extract may help reduce hair loss by promoting stem cell activity in hair follicles.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

Higher cholesterol levels increase aggressive prostate cancer risk.

The research created a detailed map of skin cells, showing that certain cells in basal cell carcinoma may come from hair follicles and could help the cancer grow.

NK cells play a role in skin diseases like eczema and psoriasis.

Cepharanthine and berbamine may affect SK channels, influencing their therapeutic effects.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

New compounds may help treat heart disease by activating specific potassium channels.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Dyclonine can effectively reduce skin issues by inhibiting the TRPV3 channel.

The research found a link between certain molecular features and the biological activity of BC3, which can help identify or create new active compounds.

The document confirms the structures of major metabolites of the CRTh2 antagonist Setipiprant and identifies minor metabolites.